- Home
- PYPD vs JFU Comparison
PYPD vs JFU Comparison
Compare PYPD & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- JFU
- Stock Information
- Founded
- PYPD 2008
- JFU 2006
- Country
- PYPD Israel
- JFU China
- Employees
- PYPD N/A
- JFU N/A
- Industry
- PYPD Medical/Dental Instruments
- JFU Finance: Consumer Services
- Sector
- PYPD Health Care
- JFU Finance
- Exchange
- PYPD Nasdaq
- JFU Nasdaq
- Market Cap
- PYPD 24.2M
- JFU 22.6M
- IPO Year
- PYPD 2020
- JFU 2019
- Fundamental
- Price
- PYPD $3.56
- JFU $1.40
- Analyst Decision
- PYPD Strong Buy
- JFU
- Analyst Count
- PYPD 2
- JFU 0
- Target Price
- PYPD $12.00
- JFU N/A
- AVG Volume (30 Days)
- PYPD 8.1K
- JFU 14.6K
- Earning Date
- PYPD 11-13-2024
- JFU 11-29-2024
- Dividend Yield
- PYPD N/A
- JFU N/A
- EPS Growth
- PYPD N/A
- JFU N/A
- EPS
- PYPD N/A
- JFU 0.09
- Revenue
- PYPD N/A
- JFU $40,614,155.00
- Revenue This Year
- PYPD N/A
- JFU N/A
- Revenue Next Year
- PYPD N/A
- JFU N/A
- P/E Ratio
- PYPD N/A
- JFU $15.02
- Revenue Growth
- PYPD N/A
- JFU N/A
- 52 Week Low
- PYPD $2.95
- JFU $1.21
- 52 Week High
- PYPD $9.20
- JFU $4.90
- Technical
- Relative Strength Index (RSI)
- PYPD 54.93
- JFU 37.85
- Support Level
- PYPD $3.30
- JFU $1.25
- Resistance Level
- PYPD $3.59
- JFU $1.51
- Average True Range (ATR)
- PYPD 0.21
- JFU 0.14
- MACD
- PYPD 0.02
- JFU -0.01
- Stochastic Oscillator
- PYPD 68.27
- JFU 30.93
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.